BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23918741)

  • 1. Prognostic markers in stage I oral cavity squamous cell carcinoma.
    Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
    Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
    Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
    Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 expression independent of human papillomavirus is associated with lower stage and longer disease-free survival in oral cavity squamous cell carcinoma.
    Satgunaseelan L; Virk SA; Lum T; Gao K; Clark JR; Gupta R
    Pathology; 2016 Aug; 48(5):441-8. PubMed ID: 27370365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
    Wang SJ; Earle C; Wong G; Bourguignon LY
    Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.
    Aga M; Kondo S; Wakisaka N; Moriyama-Kita M; Endo K; Nakanishi Y; Murono S; Sugimoto H; Ueno T; Yoshizaki T
    Auris Nasus Larynx; 2017 Apr; 44(2):213-219. PubMed ID: 27616748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined CD44, c-MET, and EGFR expression in p16-positive and p16-negative head and neck squamous cell carcinomas.
    Baschnagel AM; Tonlaar N; Eskandari M; Kumar T; Williams L; Hanna A; Pruetz BL; Wilson GD
    J Oral Pathol Med; 2017 Mar; 46(3):208-213. PubMed ID: 27442811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.
    Liang X; Zheng M; Jiang J; Zhu G; Yang J; Tang Y
    Oral Oncol; 2011 Feb; 47(2):92-7. PubMed ID: 21167768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations among pretreatment tumor necrosis and the expression of HIF-1α and PD-L1 in advanced oral squamous cell carcinoma and the prognostic impact thereof.
    Chen TC; Wu CT; Wang CP; Hsu WL; Yang TL; Lou PJ; Ko JY; Chang YL
    Oral Oncol; 2015 Nov; 51(11):1004-1010. PubMed ID: 26365985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of hypoxia-inducible factor 1α is associated with lymph node metastasis in oral squamous cell carcinoma].
    Li JN; Feng ZE; Wang L; Wang YX; Guo CB
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Feb; 50(1):26-32. PubMed ID: 29483718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP; Wang CL; Kao HK; Liang Y; Liu SC; Huang LL; Hseuh C; Hsieh YJ; Chien KY; Chang YS; Yu JS; Chi LM
    Cancer; 2013 Nov; 119(22):4003-11. PubMed ID: 23963810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
    Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
    J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between HIF-1 alpha and VEGF in oral squamous cell carcinomas: Expression patterns and quantitative immunohistochemical analysis.
    Lee LT; Wong YK; Chan MY; Chang KW; Chen SC; Chang CT; Wang J
    J Chin Med Assoc; 2018 Apr; 81(4):370-375. PubMed ID: 29289482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
    Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
    Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognosis outcome of oral squamous cell carcinoma using HIF-2α.
    Lim E; Kuo CC; Tu HF; Yang CC
    J Chin Med Assoc; 2017 Oct; 80(10):651-656. PubMed ID: 28690120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1alpha is a prognostic marker in oral squamous cell carcinomas.
    Eckert AW; Schutze A; Lautner MH; Taubert H; Schubert J; Bilkenroth U
    Int J Biol Markers; 2010; 25(2):87-92. PubMed ID: 20544685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor.
    Fillies T; Werkmeister R; van Diest PJ; Brandt B; Joos U; Buerger H
    BMC Cancer; 2005 Jul; 5():84. PubMed ID: 16035955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.